Continuing Medical Education (CME)/Continuing Professional Development (CPD) programmes
IVA’s experience covers a wide range of therapy areas, including gastrointestinal (inflammatory bowel disease, gastro-oesophageal reflux disease), dermatology (solar keratoses, skin malignancy), respiratory (chronic obstructive pulmonary disease, asthma), cardiovascular disease and metabolic syndrome, chronic pain and headaches, just to name a few.
Knowledgeable of the principles of adult education, we utilise various delivery formats, instructional designs and techniques for our face-to-face (F2F), online or blended (F2F and online) learning programmes:
- case studies and simulations
- clinical audits
- active learning modules (ALM)
Independent Medical Education (IME) programmes
Our past and ongoing IMEs resulted from successful international grant applications and can be attributed to our deep understanding of the continuing medical education structure and global requirements and our relationships with external experts, medical universities and research organisations.
New Horizons in non-Hodgkin’s lymphoma (NHL): Endpoints and Outcomes in Follicular Lymphoma
North American Central Time April 17 3:30 pm | British Summer Time April 17 9:30 pm | Australian Eastern Daylight Time April 18 6:30 am
Jointly provided by the Elsevier Office of Continuing Medical Education and In Vivo Academy Limited. Supported by an independent educational grant from F. Hoffman-La Roche Ltd.
This webinar will talk about important statistical concepts using recently published literature and evaluate the strengths, weaknesses, reproducibility (validity), and applicability of established and emerging endpoints to individual patients with non-Hodgkin’s lymphoma (NHL) or when assessing relative efficacy between regimens or cohorts. Webinar participants will be able to explore therapeutic options for NHL, specifically the most common subtype – follicular lymphoma (FL) – at clinically relevant decision points using an enhanced understanding of statistical concepts and endpoints.
On the move with haemophilia
In collaboration with Haemophilia Foundation Australia and Haemophilia Foundation of New Zealand, this programme is supported by an independent educational grant from Pfizer Independent Grants for Learning & Change in the US.
“On the move with haemophilia” is an educational resource for parents, carers and teachers that is designed to improve their knowledge and confidence in discussing, encouraging and managing exercise in young people with haemophilia. To be launched in June 2018.
Aerosolized agents for airway clearance in cystic fibrosis; when, how and why? A roundtable discussion
Jointly provided by the Elsevier Office of Continuing Medical Education and In Vivo Academy Limited and supported by an independent educational grant from F. Hoffman-La Roche Ltd.
This live webinar was a roundtable discussion between three international expert faculty in cystic fibrosis (CF). This expert faculty discussed the role of aerosolized agents for improving airway clearance, including caveats from their own extensive clinical experience in managing patients with this condition. The faculty also deliberated on strategies to improve patient adherence to CF therapy in a case study-based format. The discussions at the webinar supported participants in clinical decision making as well as in helping their patients achieve optimal benefit through adherence to their CF therapy.
Jointly provided by the Elsevier Office of Continuing Medical Education and In Vivo Academy Limited and supported by an independent educational grant from Bristol-Myers Squibb.
This CME activity, held as a satellite symposium at the 9th World Congress of Melanoma in Brisbane, Australia on 20 October 2017 and as an on-demand webcast, discussed the current practices and challenges in management of melanoma, as well as what is on the horizon for future management of melanoma patients. A panel of experts presented emerging evidence-based data and advised considerations for clinical decision making, utilizing both didactic and interactive activities by incorporating clinical cases and panel discussions.
MOTIVATE: Medication-overuse headache: education in diagnosis, prevention, management and patient education
Supported by an independent educational grant from Pfizer Independent Grants for Learning & Change.
MOTIVATE was initially offered in 2015 as a Category 1 Quality Improvement & Continuing Professional Development (QI&CPD) 6-hour Active Learning Module (ALM), accredited by the Royal Australian College of General Practitioners (RACGP), the Australian College of Rural and Remote Medicine (ACRRM) and the Australian College of Pharmacists. It is currently available as four 30-minute Category 2 QI&CPD activities.